Evidence map›Paper›PMID 41163042›Full record

ArticleJournal of animal science and biotechnology2025

Taurochenodeoxycholic acid promotes abdominal fat deposition by modulating the crosstalk between bile acid metabolism and intestinal microbiota in broilers.

Xi Sun, Chaohui Wang, Xiaoying Liu, Yun Li, Zhouzheng Ren, Xiaojun Yang, Yanli Liu

Abstract read
In one paragraph

Article in Journal of animal science and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xi SunCollege of Animal Science and Technology, Northwest A&F University, Yangling, 712100, China.
Chaohui WangCollege of Animal Science and Technology, Northwest A&F University, Yangling, 712100, China.
Xiaoying LiuCollege of Animal Science and Technology, Northwest A&F University, Yangling, 712100, China.
Yun LiCollege of Animal Science and Technology, Northwest A&F University, Yangling, 712100, China.
Zhouzheng RenCollege of Animal Science and Technology, Northwest A&F University, Yangling, 712100, China.
Xiaojun YangCollege of Animal Science and Technology, Northwest A&F University, Yangling, 712100, China.
Yanli LiuCollege of Animal Science and Technology, Northwest A&F University, Yangling, 712100, China. liuyanli@nwsuaf.edu.cn.ORCID http://orcid.org/0000-0002-8966-5011

Funding

National Key Research & Development Program of China 2023YFD1301400National Key Research & Development Program of China 2023YFF1001900National Science Foundation of China 32372910Program for Shaanxi Science & Technology 2022GD-TSLD-46-0302Program for Shaanxi Science & Technology 2023GXJS-02-01Program for Shaanxi Science & Technology 2023KXJ-243Program for Shaanxi Science & Technology L2022-QCYZX-NY-004
6 · The paper itself

Abstract

backgroundThe role of bile acids in modulating the gut microbiota and their impact on host metabolism has garnered significant attention. Taurochenodeoxycholic acid (TCDCA) is the predominant bile acid within the chicken bile acid pool and is closely related to metabolic disorders. The current study aims to investigate the potential effects of TCDCA on abdominal fat deposition in broilers. From 14 to 28 days of age, the broilers in the CON group received an oral administration of 1 mL of saline, while those in the treatment groups were administered 1 mL of a solution containing 0.05 g, 0.10 g, or 0.20 g of TCDCA.

resultsThe results showed that TCDCA treatments from 14 to 28 d had no significant effects on BW, ADFI, ADG and FCR in broilers at the age of 28 days of age. However, the abdominal fat percentage in the 0.20 g TCDCA group significantly increased, accompanied by higher TBA and HDL-c levels, as well as a reduction in apolipoprotein B levels in serum. In addition, serum triglyceride levels tended to be higher in the 0.20 g TCDCA group (P = 0.098). The 0.20 g TCDCA treatment increased the gene expressions of SREBP-1, C/EBP-α, and ELOVL6, while decreasing the mRNA abundance of ATGL and CPT-1 in the abdominal fat. Serum levels of TCDCA, TDCA, and THDCA were significantly higher after 0.20 g TCDCA administration, while TCA levels were significantly lower, as determined by the targeted bile acid metabolomics analysis. Conversely, hepatic mRNA levels of CYP7A1, CYP27A1, BAAT, and BSEP were increased in the 0.20 g TCDCA group. The oral administration of 0.20 g TCDCA also upregulated the expression of FXR, VDR, and FGF19 in abdominal fat. The 16S rRNA analysis of cecal microbiota revealed that a decrease in the Shannon and Simpson indexes in the 0.20 g TCDCA group, and an increase in the Firmicutes/Bacteroidetes ratio. LEfSe analysis revealed that the predominant bacteria in the CON group were Streptococcus and Oscillospira at the genus level, while Lactobacillus, Parabacteroides, Anaeroplasma, and Helicobacter were identified as the dominant genera in the 0.20 g TCDCA group. Functional predictions for the gut microbiota exhibited that lipid metabolism, replication and repair pathway were enhanced in the 0.20 g TCDCA group. Correlation analysis demonstrated that the abundance of Lactobacillus was positively correlated with serum levels of TCDCA, THDCA, and TDCA, while the abundance of Streptococcus and Oscillospira showed a positive correlation with serum TCA levels.

conclusionOverall, this study elucidates that the intervention of 0.20 g TCDCA may promote abdominal fat deposition by activating bile acid receptors in abdominal fat, and concurrent alterations in both the intestinal microbial community and bile acid profile.

Indexed as

Abdominal fatBroilerCecal microbiotaTaurochenodeoxycholic acid

Identifiers

PMID41163042
PMCPMC12574242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.